Professor Kim Hye-won of Hallim University's Gangnam Sacred Heart Hospital selected the 30th best health care R&D excellence in 2025
Jul 28, 2025
Professor Kim Hye-won of Dermatology Department at Hallym University Gangnam Sacred Heart Hospital (Hospital Director Lee Dong-jin) was selected as the "2025 Health and Medical R&D Excellence 30 Lines".
'Healthcare R&D Excellence and 30 Lines' is an authoritative evaluation system organized by the Ministry of Health and Welfare and the Korea Health Industry Promotion Agency, and healthcare research cases that have achieved outstanding results in papers, patents, and technology transfer are selected every year through strict screening.
Professor Kim Hye-won's research team (Dr. Um Ji-young, Researcher Kim Han-bi) was selected as an excellent performance in the field of innovative growth skin health-based technology development by developing a pain and immunity-based diagnosis platform that quantitatively identified sensitive skin under the theme of 「Sensitive skin, science diagnosis」.
This study was highly praised for presenting an evaluation system that can objectively diagnose sensitive skin through physiological and immunological indicators, and establishing an integrated diagnosis platform that encompasses clinical treatment strategies through quantitative analysis.
In addition, the study won the Outstanding Paper Award at the Korean Society of Contact Dermatitis and Allergy in June, and was recognized for its academic contribution.
Among them, the dermatology department of Hallym University Gangnam Sacred Heart Hospital operates the 「Sensitive Skin and Facial Redness Clinic" and is striving to develop treatments through patient-specific treatment and treatment as well as continuous clinical research.
Professor Kim Hye-won said, `This achievement is thanks to fellow researchers and patients who have been concerned about the delicate disease of sensitive skin. We hope that this study will lead to the development of customized treatment for patients and help in the actual medical field. "Sensitive skin is not just a skin irritation reaction, but a disease that combines neurological and immunological mechanisms. We will continue to lead the scientific diagnosis of skin diseases and develop customized treatment technology based on precision medical care. "
Meanwhile, the 30 Best Healthcare R&D Excellence in 2025 will be published as a casebook at the end of this year, and it is also recommended as a candidate for the "100 Best National R&D Excellence and 100 Best" organized by the Ministry of Science and ICT. Details can be found on the website of the Korea Health Industry Promotion Agency and the Comprehensive Health and Medical Technology Information System.
'Healthcare R&D Excellence and 30 Lines' is an authoritative evaluation system organized by the Ministry of Health and Welfare and the Korea Health Industry Promotion Agency, and healthcare research cases that have achieved outstanding results in papers, patents, and technology transfer are selected every year through strict screening.
Professor Kim Hye-won's research team (Dr. Um Ji-young, Researcher Kim Han-bi) was selected as an excellent performance in the field of innovative growth skin health-based technology development by developing a pain and immunity-based diagnosis platform that quantitatively identified sensitive skin under the theme of 「Sensitive skin, science diagnosis」.
This study was highly praised for presenting an evaluation system that can objectively diagnose sensitive skin through physiological and immunological indicators, and establishing an integrated diagnosis platform that encompasses clinical treatment strategies through quantitative analysis.
In addition, the study won the Outstanding Paper Award at the Korean Society of Contact Dermatitis and Allergy in June, and was recognized for its academic contribution.
Among them, the dermatology department of Hallym University Gangnam Sacred Heart Hospital operates the 「Sensitive Skin and Facial Redness Clinic" and is striving to develop treatments through patient-specific treatment and treatment as well as continuous clinical research.
Professor Kim Hye-won said, `This achievement is thanks to fellow researchers and patients who have been concerned about the delicate disease of sensitive skin. We hope that this study will lead to the development of customized treatment for patients and help in the actual medical field. "Sensitive skin is not just a skin irritation reaction, but a disease that combines neurological and immunological mechanisms. We will continue to lead the scientific diagnosis of skin diseases and develop customized treatment technology based on precision medical care. "
Meanwhile, the 30 Best Healthcare R&D Excellence in 2025 will be published as a casebook at the end of this year, and it is also recommended as a candidate for the "100 Best National R&D Excellence and 100 Best" organized by the Ministry of Science and ICT. Details can be found on the website of the Korea Health Industry Promotion Agency and the Comprehensive Health and Medical Technology Information System.
|
This article was translated by Naver AI translator.
